Molecular Interactions
Last updated: 2024 May 18
Total hit(s): 5252
S.No.
1
38512394
Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
2
38361363
Serological assessment of the durability of vaccine-mediated protection against SARS-CoV-2 infection.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
3
38304547
Binding affinity between coronavirus spike protein and human ACE2 receptor.
Comput Struct Biotechnol J
2024 Dec
5.11
1
4
38717195
Humoral responses to multiple SARS-CoV-2 variants after two doses of vaccine in kidney transplant patients.
Virulence
2024 Dec
4.81
1
5
38704887
Sequestration of membrane cholesterol by cholesterol-binding proteins inhibits SARS-CoV-2 entry into Vero E6 cells.
Biochem Biophys Res Commun
2024 Jul 5
2.73
1
6
38640732
Computational investigation of the inhibitory interaction of IRF3 and SARS-CoV-2 accessory protein ORF3b.
Biochem Biophys Res Commun
2024 Jun 18
2.73
1
7
38652363
Deciphering the similarities and disparities of molecular mechanisms behind respiratory epithelium response to HCoV-229E and SARS-CoV-2 and drug repurposing, a systems biology approach.
Daru
2024 Jun
2.72
1
8
38724525
Genomic characterization of Influenza A (H1N1)pdm09 and SARS-CoV-2 from Influenza Like Illness (ILI) and Severe Acute Respiratory Illness (SARI) cases reported between July-December, 2022.
Sci Rep
2024 May 9
4.12
1
9
38718213
Characterization of nsp1 Binding to the Viral RNA Leader Sequence of Severe Acute Respiratory Syndrome Coronavirus.
Biochemistry
2024 May 8
2.952
1
10
38686454
Interface design of SARS-CoV-2 symmetrical nsp7 dimer and machine learning-guided nsp7 sequence prediction reveals physicochemical properties and hotspots for nsp7 stability, adaptation, and therapeutic design.
Phys Chem Chem Phys
2024 May 8
6.3
1
11
38717584
Ultra-Sensitive Detection of the SARS-CoV-2 Nucleocapsid Protein via a Clustered Regularly Interspaced Short Palindromic Repeat/Cas12a-Mediated Immunoassay.
ACS Sens
2024 May 8
6.88
1
12
38713096
Longitudinal study of immunity to SARS-CoV2 in ocrelizumab-treated MS patients up to 2 years after COVID-19 vaccination.
Ann Clin Transl Neurol
2024 May 7
7
1
13
38710880
Proactive vaccination using multiviral Quartet Nanocages to elicit broad anti-coronavirus responses.
Nat Nanotechnol
2024 May 6
56.7
1
14
38714446
Intranasal immunization with the bivalent SARS-CoV-2 vaccine effectively protects mice from nasal infection and completely inhibits disease development.
Vaccine
2024 May 6
3.31
1
15
38715364
Single shot dendritic cell targeting SARS-CoV-2 vaccine candidate induces broad, durable and protective systemic and mucosal immune responses in mice.
Mol Ther
2024 May 6
17
2
16
38704475
Immunoinformatics design of a structural proteins driven multi-epitope candidate vaccine against different SARS-CoV-2 variants based on fynomer.
Sci Rep
2024 May 4
4.12
1
17
38703305
Emerging Trends of Gold Nanostructures for Point-of-Care Biosensor-Based Detection of COVID-19.
Mol Biotechnol
2024 May 4
4.8
1
18
38703336
Efficacy, Safety, and Pharmacokinetics of AZD7442 (Tixagevimab/Cilgavimab) for Prevention of Symptomatic COVID-19: 15-Month Final Analysis of the PROVENT and STORM CHASER Trials.
Infect Dis Ther
2024 May 4
3.95
1
19
38758996
Development and characterization of three novel mouse monoclonal antibodies targeting spike protein S1 subunit of Middle East Respiratory Syndrome Corona Virus.
Hum Antibodies
2024 May 2
1.5
1
20
38706870
Functional diversification of innate and inflammatory immune responses mediated by antibody fragment crystallizable activities against SARS-CoV-2.
iScience
2024 May 17
4.447
1
21
38638575
Longitudinal analysis of genomic mutations in SARS-CoV-2 isolates from persistent COVID-19 patient.
iScience
2024 May 17
4.447
1
22
38759218
Molecular docking based comparative study of antiviral compounds on SARS-CoV-2 spike protein.
Nat Prod Res
2024 May 17
3.9
1
23
38753442
Preclinical assessment of a recombinant RBD-Fc fusion protein as SARS-CoV-2 candidate vaccine.
Eur J Microbiol Immunol (Bp)
2024 May 16
1
24
38747636
Optimizing SARS-CoV-2 vaccine responses in kidney transplant recipients: an urgent need.
Microbiol Spectr
2024 May 15
4.6
1
25
38694063
Role of ribosomal pathways and comorbidity in COVID-19: Insight from SARS-CoV-2 proteins and host proteins interaction network analysis.
Heliyon
2024 May 15
1.65
1